Switch theme
Sign up to access all valuation multiples
MPM Corporeos SA provides laser hair removal services and facial aesthetics.
2004
n/a
LTM Revenue $190M
LTM EBITDA $41.0M
$182M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MPM Corporeos has a last 12-month revenue (LTM) of $190M and a last 12-month EBITDA of $41.0M.
In the most recent fiscal year, MPM Corporeos achieved revenue of $189M and an EBITDA of $44.6M.
MPM Corporeos expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MPM Corporeos valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $190M | XXX | $189M | XXX | XXX | XXX |
| Gross Profit | $70.5M | XXX | $63.5M | XXX | XXX | XXX |
| Gross Margin | 37% | XXX | 34% | XXX | XXX | XXX |
| EBITDA | $41.0M | XXX | $44.6M | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 24% | XXX | XXX | XXX |
| EBIT | $30.7M | XXX | $26.8M | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $4.2M | XXX | $0.5M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $102M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, MPM Corporeos's stock price is BRL 1 (or $0).
MPM Corporeos has current market cap of BRL 361M (or $66.4M), and EV of BRL 990M (or $182M).
See MPM Corporeos trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $182M | $66.4M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, MPM Corporeos has market cap of $66.4M and EV of $182M.
MPM Corporeos's trades at 1.0x EV/Revenue multiple, and 4.1x EV/EBITDA.
Equity research analysts estimate MPM Corporeos's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
MPM Corporeos has a P/E ratio of 15.7x.
See valuation multiples for MPM Corporeos and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $66.4M | XXX | $66.4M | XXX | XXX | XXX |
| EV (current) | $182M | XXX | $182M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 4.4x | XXX | 4.1x | XXX | XXX | XXX |
| EV/EBIT | 5.9x | XXX | 6.8x | XXX | XXX | XXX |
| EV/Gross Profit | 2.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 15.7x | XXX | 143.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 11.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMPM Corporeos's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
MPM Corporeos's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
MPM Corporeos's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for MPM Corporeos and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 24% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| SynBiotic | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MPM Corporeos acquired XXX companies to date.
Last acquisition by MPM Corporeos was XXXXXXXX, XXXXX XXXXX XXXXXX . MPM Corporeos acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was MPM Corporeos founded? | MPM Corporeos was founded in 2004. |
| Where is MPM Corporeos headquartered? | MPM Corporeos is headquartered in Brazil. |
| Is MPM Corporeos publicy listed? | Yes, MPM Corporeos is a public company listed on BVMF. |
| What is the stock symbol of MPM Corporeos? | MPM Corporeos trades under ESPA3 ticker. |
| When did MPM Corporeos go public? | MPM Corporeos went public in 2021. |
| Who are competitors of MPM Corporeos? | Similar companies to MPM Corporeos include e.g. Acme United, EZZ Life Science, Lavipharm, Sarantis Group. |
| What is the current market cap of MPM Corporeos? | MPM Corporeos's current market cap is $66.4M |
| What is the current revenue of MPM Corporeos? | MPM Corporeos's last 12 months revenue is $190M. |
| What is the current EV/Revenue multiple of MPM Corporeos? | Current revenue multiple of MPM Corporeos is 1.0x. |
| Is MPM Corporeos profitable? | Yes, MPM Corporeos is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of MPM Corporeos? | MPM Corporeos's last 12 months EBITDA is $41.0M. |
| What is MPM Corporeos's EBITDA margin? | MPM Corporeos's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of MPM Corporeos? | Current EBITDA multiple of MPM Corporeos is 4.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
